The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04014738

Enrollment

100

Registered

2019-07-10

Start date

2019-07-20

Completion date

2020-12-31

Last updated

2019-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal Carcinoma

Brief summary

It is well established that HPV infection has a casual and is a prognostic factor in several cancer types, including oropharynx. We wish to examine if HPV infection has a prognostic significance in nasopharyngeal carcinoma.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* nasopharyngeal carcinoma patients treated in our institute between 2008-2018

Exclusion criteria

* missing clinical data * 2nd Head and neck primary cancer * very locally advanced or distant metastatic nasopharyngeal carcinoma * Prior radiation therapy to the head and neck region

Design outcomes

Primary

Measure	Time frame
Overall survival	6 months

Countries

Israel

Contacts

Primary ContactEran S Fridman, MD

eran.frid@gmail.com+972-4-7772480

Outcome results